CCDC88C-FLT3 gene fusion in CD34-positive haematopoietic stem and multilineage cells in myeloid/lymphoid neoplasm with eosinophilia

Yuya Kurihara; Hideaki Mizuno; Akira Honda; Arika Shimura; Yosei Fujioka; Hiroaki Maki; Mineo Kurokawa

doi:10.1111/jcmm.17143

CCDC88C-FLT3 gene fusion in CD34-positive haematopoietic stem and multilineage cells in myeloid/lymphoid neoplasm with eosinophilia

J Cell Mol Med. 2022 Feb;26(3):950-952. doi: 10.1111/jcmm.17143. Epub 2022 Jan 12.

Authors

Yuya Kurihara¹, Hideaki Mizuno¹, Akira Honda¹, Arika Shimura¹, Yosei Fujioka¹, Hiroaki Maki¹, Mineo Kurokawa^{1

2}

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
² Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.

No abstract available

Keywords: CCDC88C-FLT3; allogeneic haematopoietic stem cell transplantation; myeloid/lymphoid neoplasms with eosinophilia; stem and multilineage cells; tyrosine kinase inhibitor.

Publication types

Letter

MeSH terms

Eosinophilia* / genetics
Gene Fusion
Hematopoietic Stem Cell Transplantation*
Humans
Intracellular Signaling Peptides and Proteins / genetics
Leukemia, Myeloid, Acute* / genetics
Lymphoma* / genetics
Microfilament Proteins / genetics
Myeloproliferative Disorders* / genetics
fms-Like Tyrosine Kinase 3 / genetics

Substances

CCDC88C protein, human
Intracellular Signaling Peptides and Proteins
Microfilament Proteins
FLT3 protein, human
fms-Like Tyrosine Kinase 3